SPARC Induces COL1A1/COL3A1 Expressions Representing Aggressive Molecular Cancer-Associated Fibroblasts Signatures...

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment Research

Background:

• Secreted protein, acidic and rich in cysteine (SPARC) is implicated in tumor metastasis, but its precise role in the tumor microenvironment (TME) is not fully understood.
• Stromal overexpression of SPARC may indicate colorectal cancer (CRC) progression.

Purpose of the Study:

• To investigate the clinical and functional significance of SPARC in colorectal cancer (CRC) metastasis.
• To elucidate the molecular mechanisms by which SPARC influences the tumor microenvironment (TME).

Main Methods:

• Exploration of SPARC molecular status in CRC tumors.
• SPARC knockdown in cancer-associated fibroblasts (CAFs).
• Analysis of gene expression (COL1A1/COL3A1, secretome genes) and the CSF1/CSF1R axis.

Main Results:

• SPARC expression is specific to CRC stroma and has prognostic value.
• SPARC knockdown in CAFs reduced metastatic phenotypes and suppressed COL1A1/COL3A1 and secretome genes.
• The CSF1/CSF1R axis is crucial for SPARC-driven cancer invasion.
• CAF-associated genes (CAFGs), including COL genes, are prognostic indicators.

Conclusions:

• SPARC promotes metastasis by inducing collagen and secretome genes in the TME, acting detrimentally to the host.
• These findings enhance understanding of aggressive TME and identify potential therapeutic targets for cancer metastasis.